A recent trial suggests patients with poorly controlled type 2 diabetes who participated in a 9-month telemonitoring intervention had better glycemic control and a significant reduction in blood pressure than a similar group of participants who received usual care (Wild SH et al. PLoS Med. doi:10.1371/journal.pmed.1002098 [published online July 26, 2016]). The burden of telemonitoring patients with diabetes wasn’t in time but in cost; the intervention added $372.85 per patient.
Slomski A. Telemonitoring Helps Keep Diabetes Under Control. JAMA. 2016;316(12):1250. doi:10.1001/jama.2016.13589